Thiazolidinediones (glitazones)

Journal articles and book chapters

05-01-2018 | Cardiovascular outcomes | Review | Article

Pharmacological prevention of cardiovascular outcomes in diabetes mellitus: Established and emerging agents

Saxon DR, Rasouli N, Eckel RH. Drugs 2018; 78: 203–214. doi: 10.1007/s40265-017-0857-3

04-01-2018 | Medication adherence | Article

A class comparison of medication persistence in people with type 2 diabetes: A retrospective observational study

McGovern A et al. Diabetes Ther 2018; 9: 229–242. doi: 10.1007/s13300-017-0361-5

02-11-2017 | Heart failure | Review | Article

Treating disease mechanisms in patients with heart failure and diabetes mellitus

Trang A, Aguilar D. Curr Heart Fail Rep 2017; 14: 445–453. doi: 10.1007/s11897-017-0371-7

23-10-2017 | Insulin | Review | Article

Insulin and its cardiovascular effects: What is the current evidence?

Dongerkery SP, Schroeder PR, Shomali ME. Curr Diab Rep 2017; 17: 120. doi: 10.1007/s11892-017-0955-3

23-10-2017 | Cardiovascular disorders | Review | Article

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: Recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

Schernthaner G et al. Cardiovasc Diabetol 2017; 16: 137. doi: 10.1186/s12933-017-0622-7

27-09-2017 | Dyslipidemia | Review | Article

Treatment of dyslipidemia in diabetes: Recent advances and remaining questions

Chait A, Goldberg I. Curr Diab Rep 2017; 17: 112. doi: 10.1007/s11892-017-0942-8

08-09-2017 | Latent autoimmune diabetes of adulthood | Review | Article

Adult-onset autoimmune diabetes: Current knowledge and implications for management

Nat Rev Endocrinol 2017; 13: 674–686. doi: 10.1038/nrendo.2017.99

31-07-2017 | Diabetes prevention | Review | Article

Pharmaceutical interventions for diabetes prevention in patients at risk

Chatterjee S, Davies M, Khunti K. Am J Cardiovasc Drugs 2017; 1: 13–24. doi: 10.1007/s40256-017-0239-y

02-02-2017 | Cardiovascular outcomes | Review | Article

Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes

Xu J, Rajaratnam R. Cardiovasc Diabetol 2017; 16: 18. doi: 10.1186/s12933-017-0499-5

15-11-2016 | Heart failure | Review | Article

Novel anti-glycemic drugs and reduction of cardiovascular risk in diabetes: Expectations realized, promises unmet

Flory JH, Ukena JK, Floyd JS. Curr Atheroscler Rep 2016; 18: 79. doi: 10.1007/s11883-016-0633-y

10-11-2016 | Type 2 diabetes | Review | Article

Clinical pharmacokinetics and pharmacodynamics of antihyperglycemic medications in children and adolescents with type 2 diabetes mellitus

Akhlaghi F et al. Clin Pharmacokinet 2017; 56: 561–571. doi:10.1007/s40262-016-0472-6

21-09-2016 | Heart failure | Article

Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes

Fitchett DH, Udell JA, Inzucchi SE. Eur J Heart Fail 2017; 19: 43–53. doi: 10.1002/ejhf.633

16-09-2016 | Dyslipidemia | Review | Article

PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD

Nat Rev Endocrinol 2017; 13: 36–49. doi: 10.1038/nrendo.2016.135

17-05-2016 | Heart failure | Review | Article

Treating diabetes in patients with heart failure: Moving from risk to benefit

DeFilippis EM, Givertz MM. Curr Heart Fail Rep 2016; 13: 111–118. doi: 10.1007/s11897-016-0291-y

01-03-2016 | Diabetes prevention | Book chapter | Article

Prevention of type 2 diabetes mellitus

Horton ES. In: Principles of Diabetes Mellitus. Edited by Poretsky L. Springer International Publishing, 2015. doi: 10.1007/978-3-319-20797-1_50-1

25-08-2015 | Metabolic surgery | Article

Clinical management of type 2 diabetes mellitus after bariatric surgery

Khanna V, Kashyap SR. Curr Atheroscler Rep 2015; 17: 59. doi: 10.1007/s11883-015-0537-2

24-10-2014 | Metabolic syndrome | Review | Article

Pharmacological treatment and therapeutic perspectives of metabolic syndrome

Lim S, Eckel RH. Rev Endocr Metab Disord 2014; 15: 329–341. doi: 10.1007/s11154-014-9298-4